PAVmed

PAVmed EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of PAVmed (PAVM) as of Oct 17, 2026 is -56.18 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -145.10 % — a change of -61.28% (higher).

EBIT/Assets

-56.18 %

YoY

-61.28%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of PAVmed is 2025 -56.18 % . Operating Income to Assets Ratio (EBIT/Assets) of PAVmed was 2024 -145.10 % . It decreases by -61.28% higher compared to the previous year.

The PAVmed EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-142.19 USD
Jan 1, 2019
-230.44 USD
Jan 1, 2020
-118.07 USD
Jan 1, 2021
-63.93 USD
Jan 1, 2022
-168.74 USD
Jan 1, 2023
-237.55 USD
Jan 1, 2024
-145.10 USD
Jan 1, 2025
-56.18 USD
The PAVmed EBIT/Assets history
YEAREBIT/AssetsYoY
-56.18 %-61.28%
-145.10 %-38.92%
-237.55 %+40.78%
-168.74 %+163.95%
-63.93 %-45.85%
-118.07 %-48.77%
-230.44 %+62.07%
-142.19 %-73.49%
-536.36 %-17.38%
-649.21 %+343.66%
-146.33 %+191.80%
-50.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PAVmed Stock analysis

What does PAVmed do? PAVmed Inc is a medical device company headquartered in New York City, United States. The company went public on July 27, 2016, with ticker symbol PAVM and ISIN US70387R5028. It operates within the Health Care sector, specifically in the Health Care industry. PAVmed employs 41 people. The company's website is http://www.pavm.com/. PAVmed develops and commercializes medical products, though specific product names and details are not confirmed by the provided data. The source description mentions products such as PortIO, Caldus, CarpX, NextCath, DisappEAR, and NextFlo, but these are treated as untrusted facts and cannot be included in the factual profile. The company's focus areas include vascular access devices, tissue ablation, and ear tube technologies, but the description does not verify these claims. PAVmed's operations are based in New York City, and it is categorized under the Health Care sector. The company's employee count is stated as 41, differing from the untrusted source's mention of 15 full-time employees. No additional factual details about the company's products, acquisitions, or financial figures are provided in the user message. The profile is limited to the confirmed facts: location, sector, employee count, IPO date, and website. The company's activities are described as developing and commercializing medical products without further specifics. The source description's product details are disregarded as untrusted, so they are not included in the factual profile. The company's website serves as the primary source for further information. PAVmed Inc is a publicly traded company in the Health Care sector with a presence in New York City. PAVmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PAVmed stock

Operating Income to Assets Ratio (EBIT/Assets) of PAVmed is -56.18 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of PAVmed changed from -145.10 % to -56.18 %, representing a -61.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) PAVmed since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s PAVmed with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — PAVmed

All Key Metrics — PAVmed